Adamia, S., Reiman, T., Crainie, M., Mant, M. J., Belch, A. R., & Pilarski, L. M. (2005). Intronic splicing of hyaluronan synthase 1 (HAS1): A biologically relevant indicator of poor outcome in multiple myeloma. The American Society of Hematology.
Chicago Style CitationAdamia, Sophia, Tony Reiman, Mary Crainie, Michael J. Mant, Andrew R. Belch, i Linda M. Pilarski. Intronic Splicing of Hyaluronan Synthase 1 (HAS1): A Biologically Relevant Indicator of Poor Outcome in Multiple Myeloma. The American Society of Hematology, 2005.
Cita MLAAdamia, Sophia, et al. Intronic Splicing of Hyaluronan Synthase 1 (HAS1): A Biologically Relevant Indicator of Poor Outcome in Multiple Myeloma. The American Society of Hematology, 2005.
Atenció: Aquestes cites poden no estar 100% correctes.